Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 39OTHER 10NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 24Other solid neoplasm 24Gastrointestinal 12Gynecologic 7Genitourinary 3Sarcoma 2Breast 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Endocrine 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 114Head and Neck Neoplasms 98Thyroid Neoplasms 55Salivary Gland Neoplasms 55Oropharyngeal Neoplasms 35Mouth Neoplasms 33Tongue Neoplasms 30Thyroid Cancer, Papillary 26Laryngeal Neoplasms 26Adenocarcinoma, Follicular 23Nasopharyngeal Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Breast Neoplasms 21Hypopharyngeal Neoplasms 20Uterine Cervical Neoplasms 19Colonic Neoplasms 19Carcinoma, Medullary 16Rectal Neoplasms 15Pancreatic Neoplasms 15Esthesioneuroblastoma, Olfactory 15Esophageal Neoplasms 15Anus Neoplasms 15Neoplasms 14Lung Neoplasms 14Thyroid Carcinoma, Anaplastic 13Stomach Neoplasms 13Melanoma 13Carcinoma, Renal Cell 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11

Interventions

talazoparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Mesothelioma × Head & Neck × Clear all
NCT02567396 2017-04-24

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

National Cancer Institute (NCI)

Phase 1 Withdrawn
BreastGastrointestinalGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡